Klein Lab at Yale • Mechanistic Viewer

Mechanism of ROS1 activation and inhibition

Ligand engagement
Antibody blockade
Inactive Monomer
Drag to rotate. Scroll to zoom. Hover for domain labels.

Unliganded ROS1

A bent ectodomain tucks the small CATCH hand into a pocket around the YWTD-B hip domain. The arm and hand move as one rigid unit, the leg stays constrained, and ROS1 remains inactive.

Ligand None
Leg dynamics Constrained
Oligomer No
Activity Off

What the model encodes

The domain structure of ROS1 from N-terminus to C-terminus: CATCH, FNIII-1, FNIII-2, YWTD-A, FNIII-3, YWTD-B, FNIII-4, FNIII-5, YWTD-C, FNIII-6, FNIII-7, FNIII-8, FNIII-9, and then the transmembrane helix.

Structural anchors

This is a mechanistic cartoon, not an atom-by-atom simulation. It is grounded in the structures reported in our ROS1 paper and the linked PDB entries: 9PVP, 10FT, 10GH, 9DZ4, and 9PWQ.

Mechanistic logic

In the inactive and site-1 clustered states, the CATCH hand stays parked in the YWTD-B hip pocket. In the active state, NELL2 remains anchored at site 1 on YWTD-A while the arm flips upward as a rigid CATCH plus FNIII-1/2 body, adding site 2 on FNIII-2 and site 3 on FNIII-1. The NELL2 trimer itself stays rigid, with the same fixed conformation whether it is bound or unbound off to the side. CATCH does not bind NELL2; it simply releases from YWTD-B so the legs can come closer together and the kinase regions can engage.

Antibody blockade

RX5 is drawn as a Y-shaped antibody whose one Fab tip caps the site-1 epitope on YWTD-A and prevents productive NELL2 recruitment. CT4 is drawn as the same Y-shaped antibody, but with one Fab tip docked into the arm-shoulder interface so the arm cannot flip up to add site 2 on FNIII-2 and site 3 on FNIII-1, trapping a pre-active clustered state.